Privia Health Group Stock Fundamentals

PRVA Stock  USD 18.17  0.63  3.35%   
Privia Health Group fundamentals help investors to digest information that contributes to Privia Health's financial success or failures. It also enables traders to predict the movement of Privia Stock. The fundamental analysis module provides a way to measure Privia Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Privia Health stock.
At present, Privia Health's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 114.1 M, whereas Tax Provision is forecasted to decline to (7.8 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Privia Health Group Company Return On Equity Analysis

Privia Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Privia Health Return On Equity

    
  0.0373  
Most of Privia Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Privia Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Privia Total Stockholder Equity

Total Stockholder Equity

383.76 Million

At present, Privia Health's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Privia Health Group has a Return On Equity of 0.0373. This is 100.16% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 112.03% lower than that of the firm.

Privia Health Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Privia Health's current stock value. Our valuation model uses many indicators to compare Privia Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Privia Health competition to find correlations between indicators driving Privia Health's intrinsic value. More Info.
Privia Health Group is regarded fourth in return on equity category among related companies. It is rated below average in return on asset category among related companies reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Privia Health Group is roughly  2.59 . At present, Privia Health's Return On Equity is projected to slightly decrease based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Privia Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Privia Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Privia Health's earnings, one of the primary drivers of an investment's value.

Privia Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Privia Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Privia Health could also be used in its relative valuation, which is a method of valuing Privia Health by comparing valuation metrics of similar companies.
Privia Health is currently under evaluation in return on equity category among related companies.

Privia Fundamentals

About Privia Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Privia Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Privia Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Privia Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-345.5 M-328.2 M
Total Revenue1.7 B1.1 B
Cost Of Revenue1.5 BB
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.07  0.08 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue(0.000068)(0.000072)
Revenue Per Share 14.20  7.60 
Ebit Per Revenue 0.01  0.01 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Privia Health Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:
Check out Privia Health Piotroski F Score and Privia Health Altman Z Score analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Privia Stock analysis

When running Privia Health's price analysis, check to measure Privia Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Privia Health is operating at the current time. Most of Privia Health's value examination focuses on studying past and present price action to predict the probability of Privia Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Privia Health's price. Additionally, you may evaluate how the addition of Privia Health to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Privia Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.83)
Earnings Share
0.19
Revenue Per Share
14.201
Quarterly Revenue Growth
0.21
Return On Assets
0.0144
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Privia Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.